Why We Invested in Resilient Lifescience — Preventing Opioid Overdose

Thumb1

blank

Enthusiastic to announce our financial investment in Resilient Lifescience, which is taking on the opioid epidemic by acquiring a wearable method to detect and instantly reverse overdoses. Tau Ventures is an AI-1st fund in Silicon Valley investing mainly in seed and we often choose before or later bets when we see huge guarantee. We are also investing in US / Canada but in exceptional scenarios will think about a offer exterior. Resilient was established in 2022 in Pittsburgh and impressed us with (1) a solid will need, (2) developing an execution-centered team, and (3) their organization strategy.

1) The Want

The opioid crisis is truly a tragedy that prices $1T for each 12 months, touching all the 5Ps (payors, companies, clients, pharma, policymakers). Particularly, tlisted here are now about 75,000 opioid overdose fatalities for each calendar year in the US, and the vast majority of them occur when nobody is all around to administer aid (CDC, rand.org). We are particularly familiar with this house presented our investment in Marigold Wellness.

blank

2) The Staff

We believed the cofounder’s backgrounds speak for themselves: https://www.linkedin.com/in/bradfordholden and https://www.linkedin.com/in/charlierproctor. CEO Brad was a Maritime for 4 years together with currently being a Platoon Commander in Afghanistan. CTO Charlie was an engineer at Google. They fulfilled at Infinitus, yet another Tau portfolio business, and their CEO invested individually and is the 1 who introed us.

blank

3) Business enterprise Approach

Hardware is difficult, as the bar for finding all the things appropriate is significantly larger than in application, even a lot more so in health care. Producing and distribution costs also create a really distinct price tag structure than program ventures. We see a pathway for them to gather much more info and bolster the analytics / AI piece of the merchandise. We respect the CEO’s approach to do customer discovery and subvert the typical archetype of clinical products remaining cash intensive. We also subscribe to their thesis that getting in Pittsburgh will retain expenses minimal and let them obtain to terrific talent, in particular in engineering from Carnegie Mellon.

blankWe are honored and energized to be portion of Resilient’s journey, applying technology to solve a huge problem. More at https://www.resilient.bio.


At first revealed on “Information Pushed Investor,” am satisfied to syndicate on other platforms. I am the Managing Spouse and Cofounder of Tau Ventures with 20 several years in Silicon Valley throughout corporates, have startup, and VC funds. These are purposely limited content focused on realistic insights (I connect with it gldr — fantastic size did read). A lot of of my writings are at https://www.linkedin.com/in/amgarg/depth/latest-action/posts and I would be stoked if they get individuals interested more than enough in a subject to examine in even further depth. If this post had valuable insights for you comment away and/or give a like on the write-up and on the Tau Ventures’ LinkedIn webpage, with thanks many thanks for supporting our function. All views expressed below are my own.